Recovery of vision after adjuvant thalidomide in a child with tuberculous meningitis and acute lymphoblastic leukemia

Journal of Child Neurology

Volumn 24, Issue 2, 2009, Pages 166-169

  Stefan, Daniela Cristina ^a,b   Andronikou, Savvas ^a   Freeman, Nicola ^a   Schoeman, Johan ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

Acute lymphoblastic leukemia; Brain abscess; Loss of vision; Thalidomide; Tuberculous meningitis

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CEFTRIAXONE; ETHIONAMIDE; ISONIAZID; PREDNISONE; PYRAZINAMIDE; RIFAMPICIN; THALIDOMIDE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BACTERIAL MENINGITIS; BLINDNESS; BRAIN ABSCESS; BRAIN INFARCTION; CASE REPORT; CHILD HOSPITALIZATION; CORTICOSTEROID THERAPY; HUMAN; LUMBAR PUNCTURE; LUNG TUBERCULOSIS; MAINTENANCE THERAPY; MALE; NEUROIMAGING; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; OPTIC CHIASM; OPTIC NERVE ATROPHY; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE DRUG DOSE; TREATMENT OUTCOME; TUBERCULOUS MENINGITIS;

ADRENAL CORTEX HORMONES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLINDNESS; BRAIN; CHEMOTHERAPY, ADJUVANT; CHILD; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE IMAGING; MALE; OPTIC CHIASM; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECOVERY OF FUNCTION; THALIDOMIDE; TUBERCULOSIS, MENINGEAL; VISION, OCULAR;

EID: 59649118675     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073808322329     Document Type: Article

References (19)

1. Roberts MT, Mendelson M., Meyer P., Charmichael A., Lever AM The use of thalidomide in the treatment of intracranial tuberculomas. J Infect. 2003;4:251-255.
2. Schoeman JF, Fieggen G., Seller N., Mendelson M., Hartzenberg B. Intractable intracranial tuberculous infection responsive to thalidomide: Report of four cases. J Child Neurol. 2006;21:301-308.
3. Stefan DC, Kruis AL, Schaaf HS, Wessels G. Tuberculosis in oncology patients. Ann Trop Paediatr. 2008;28:111-116.
4. Henrickson M., Weisse ME Tuberculous brain abscess in a three year old South Pacific Islander. Pediatr Infect Dis J. 1992;11:488-491.
5. Tang ESC, Chau A., Fong D., Humphries MJ The treatment of multiple tuberculous brain abscesses: A case report. J Neurol. 1991;238:183-185.
6. Afghani B., Liberman JM Paradoxical enlargement or development of intracranial tuberculomas during therapy: Case report and review. Clin Infect Dis. 1994;19:1092-1099.
7. Chambers ST, Hendrickse WA, Record C., Rudge P., Smith H. Paradoxical expansion of tuberculomas during chemotherapy. Lancet. 1984;2:181-183.
8. Garg RK Tuberculosis of the central nervous system. J Postgrad Med. 1999;75:133-140.
9. Tsenova L., Bergtold A., Freedman VH, Kaplan G. Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system. Proc Natl Acad Sci USA. 1999;96:5657-5662.
10. Flynn JL, Goldstein MM, Chan J., et al. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity. 1995;2:561-572.
11. Tsenova L., Sokol K., Freedman VH, Kaplan G. A combination of thalidomide plus antibiotics protects rabbits from mycobacterial meningitis-associated death. J Infect Dis. 1998;177:1563-1572.
12. Schoeman JF, Springer P., Ravenscroft A., et al. Adjunctive thalidomide therapy of childhood tuberculous meningitis: Possible anti-inflammatory role. J Child Neurol. 2000;15:497-503.
13. Bekker LG, Haslett P., Maartens G., Steyn L., Kaplan G. Thalidomide-induced antigen-specific immune stimulation in patients with human immunodeficiency virus type 1 and tuberculosis. J Infect Dis. 2000;181:954-65.
14. Schoeman JF, Van Zyl LE, Laubscher JA, Donald PR Serial CT scanning in childhood tuberculous meningitis: Prognostic features in 198 cases. J Child Neurol. 1995;10:320-329.
15. Haslett PA, Roche P., Butlin CR, et al. Effective treatment of erythema nodosum leprosum with thalidomide is associated with immune stimulation. J Infect Dis. 2005;192:2045.
16. Gordon JN, Goggin PM Thalidomide and its derivatives: Emerging from the wilderness. Postgrad Med J. 2003;79:127-132.
17. Udani PM, Bhat US, Dastur DK Tuberculosis of central nervous system. Indian Pediatr. 1973;11:647-656.
18. Navarro IM, Peralta VH, Leon JA, Varela EA, Cabrera JM Tuberculous optochiasmatic arachnoiditis. Neurosurgery. 1981;9:654-660.
19. Haslett PA, Corral LG, Albert M., Kaplan G. Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset. J Exp Med. 1998;187:1885-1892.